Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey J Adam

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Cancer Journal (Sudbury, Mass.)|October 2, 2018
The Partnership for Accelerating Cancer TherapiesRebecca G Baker, Axel X Hoos, Stacey J Adam, et al.
Critical Care Medicine|September 8, 2021
Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical TrialsTimothy G Buchman, Ruxandra Draghia-Akli, Stacey J Adam, et al.
Oncogene|October 7, 2022
MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changesDelaney K Sullivan, Anja Deutzmann, Josiah Yarbrough, et al.
Molecular Therapy. Nucleic Acids|August 18, 2020
MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCCRenumathy Dhanasekaran, Jangho Park, Alekesey Yevtodiyenko, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in OncologyLaurent Dercle, Dana E Connors, Ying Tang, et al.
Nature Immunology|March 20, 2025
Navigating the path forward for evidence-based management of long COVIDJoseph J Breen, Robert W Eisinger, Sarah W Read, et al.
Journal of Clinical and Translational Science|October 31, 2024
Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the futureStacey J Adam, Timothy G Buchman, Judith S Currier, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2015
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolismEmelyn H Shroff, Livia S Eberlin, Vanessa M Dang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate EvaluationMichael L Maitland, Julia Wilkerson, Sanja Karovic, et al.
Journal of Clinical and Translational Science|November 14, 2024
Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiativeDavid A Wohl, Stacey J Adam, Kevin W Gibbs, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Cancer Journal (Sudbury, Mass.)|October 2, 2018
The Partnership for Accelerating Cancer TherapiesRebecca G Baker, Axel X Hoos, Stacey J Adam, et al.
Critical Care Medicine|September 8, 2021
Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical TrialsTimothy G Buchman, Ruxandra Draghia-Akli, Stacey J Adam, et al.
Oncogene|October 7, 2022
MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changesDelaney K Sullivan, Anja Deutzmann, Josiah Yarbrough, et al.
Molecular Therapy. Nucleic Acids|August 18, 2020
MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCCRenumathy Dhanasekaran, Jangho Park, Alekesey Yevtodiyenko, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in OncologyLaurent Dercle, Dana E Connors, Ying Tang, et al.
Nature Immunology|March 20, 2025
Navigating the path forward for evidence-based management of long COVIDJoseph J Breen, Robert W Eisinger, Sarah W Read, et al.
Journal of Clinical and Translational Science|October 31, 2024
Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the futureStacey J Adam, Timothy G Buchman, Judith S Currier, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2015
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolismEmelyn H Shroff, Livia S Eberlin, Vanessa M Dang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate EvaluationMichael L Maitland, Julia Wilkerson, Sanja Karovic, et al.
Journal of Clinical and Translational Science|November 14, 2024
Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiativeDavid A Wohl, Stacey J Adam, Kevin W Gibbs, et al.
Pageof 5